{"cdcTestId":"2019-0011","testcaseName":"Dose #1 of Hep A at age 18 years","vaccineGroup":"HepA","evaluationTestType":"Age: At Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2004-10-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep A, adult","cvx":"52","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2023-04-19T00:00:00","recommendedDate":"2023-04-19T00:00:00","pastDueDate":"2023-04-19T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep A, adult","cvx":"52","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2019-09-19T20:00:00","dateUpdated":"2020-05-29T08:30:17.594","generalDescription":"This test case describes when dose #1 of the Hep A vaccine is administered to an adolescent that a second dose should be forecast.","changedInVersion":"4.3","reasonForChange":""}